- Home
- ZBIO vs NECB Comparison
ZBIO vs NECB Comparison
Compare ZBIO & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- NECB
- Stock Information
- Founded
- ZBIO 2019
- NECB 1934
- Country
- ZBIO United States
- NECB United States
- Employees
- ZBIO N/A
- NECB N/A
- Industry
- ZBIO
- NECB Savings Institutions
- Sector
- ZBIO
- NECB Finance
- Exchange
- ZBIO NYSE
- NECB Nasdaq
- Market Cap
- ZBIO 268.7M
- NECB 294.0M
- IPO Year
- ZBIO 2024
- NECB N/A
- Fundamental
- Price
- ZBIO $7.83
- NECB $23.14
- Analyst Decision
- ZBIO Strong Buy
- NECB
- Analyst Count
- ZBIO 6
- NECB 0
- Target Price
- ZBIO $29.20
- NECB N/A
- AVG Volume (30 Days)
- ZBIO 207.0K
- NECB 49.2K
- Earning Date
- ZBIO 03-04-2025
- NECB 01-29-2025
- Dividend Yield
- ZBIO N/A
- NECB 2.81%
- EPS Growth
- ZBIO N/A
- NECB 7.83
- EPS
- ZBIO N/A
- NECB 3.58
- Revenue
- ZBIO N/A
- NECB $105,835,000.00
- Revenue This Year
- ZBIO N/A
- NECB N/A
- Revenue Next Year
- ZBIO N/A
- NECB $8.02
- P/E Ratio
- ZBIO N/A
- NECB $6.46
- Revenue Growth
- ZBIO N/A
- NECB 6.02
- 52 Week Low
- ZBIO $5.83
- NECB $14.26
- 52 Week High
- ZBIO $26.25
- NECB $31.72
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- NECB 30.92
- Support Level
- ZBIO N/A
- NECB $23.42
- Resistance Level
- ZBIO N/A
- NECB $24.17
- Average True Range (ATR)
- ZBIO 0.00
- NECB 0.67
- MACD
- ZBIO 0.00
- NECB -0.12
- Stochastic Oscillator
- ZBIO 0.00
- NECB 3.69
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. They conduct their activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.